Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults

October 26, 2023 updated by: Diane S. Mendoza-Sarmiento, University of Santo Tomas
The primary purpose of this clinical trial is to investigate whether the consumption of pigmented rice (black rice) in the diet improves cardiovascular health, specifically body weight, lipids, and glucose levels. It also aims to know whether people enjoyed eating pigmented rice and if they would continue eating it.

Study Overview

Detailed Description

The goal of this clinical trial is to test if pigmented rice consumption can lower the cardiometabolic risk factors of adults. The main question[s] it aims to answer are:

  • Will pigmented rice significantly reduce lipid levels compared to white rice after six weeks?
  • Will pigmented rice significantly reduce glucose levels compared to white rice after six weeks? Will pigmented rice significantly reduce weight and waist-hip ratio levels compared to white rice after six weeks? What are the participants' experiences in consuming pigmented rice?

Participants will consume black-pigmented rice for six weeks while maintaining their usual physical activity. Researchers will compare the white rice group and the black rice group to see if lowers cardiometabolic risk factors.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Metro Manila
      • Manila, Metro Manila, Philippines, 1015
        • University of Santo Tomas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 20-59 years.
  • Body mass index between 18.5 -35 kg/m2
  • Elevated cholesterol (total cholesterol >200 mg/dL or LDL cholesterol 130-190 mg/dL), and/or impaired fasting glucose (100-125mg/dL)
  • Eat rice as a staple food at least twice per day

Exclusion Criteria:

  • Are pregnant or lactating
  • Regularly consume pigmented rice (two meals per day in the past 4 weeks)
  • Have cardiovascular disease (hypertension, stroke, ischemic heart disease, myocardial infarction, or congestive heart failure) or diabetes mellitus
  • Take cholesterol or glucose-lowering medications
  • Have elevated blood pressure (>130/80 mmHg)
  • Have an illness that may influence lipid metabolism or metabolic rate (liver cirrhosis, pancreatitis, chronic kidney disease, hyperthyroidism, hypothyroidism)
  • Take supplements that may influence lipids and glucose levels (including polyphenols)
  • Are on a strict diet regimen (calorie-restricted or excluding food groups, examples: (Examples: Ketogenic diet, Intermittent fasting, No Rice diet)
  • Have an active lifestyle (Ex. Goes to the gym daily, regularly (≥3 times a week) and perform vigorous activities such as lifting weights, swimming, cycling fast or uphill, or running, or athlete)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: White Rice
Cooked white rice will be consumed by the control group for six weeks (twice per day)
Cooked white rice
Experimental: Pigmented Rice
Cooked black pigmented rice will be consumed for six weeks (twice per day)
Cooked black rice
Other Names:
  • Black Rice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Lipid Levels
Time Frame: six weeks
Total cholesterol, Low-density lipoprotein, high-density lipoprotein, triglycerides
six weeks
Change in Glucose Level
Time Frame: Six weeks
Fasting blood glucose
Six weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Weight (kg)
Time Frame: Six weeks
Weight in kilograms
Six weeks
Change in Waist Circumference (cm)
Time Frame: six weeks
Waist circumference in centimeters
six weeks
Change in Hip Circumference (cm)
Time Frame: Six weeks
Hip Circumference in centimeters
Six weeks
Change in Waist:Hip (W:H ratio)
Time Frame: Six weeks
Waist and hip measurement will be combined to report W:H ratio
Six weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alison M Hill, Ph.D, University of South Australia
  • Principal Investigator: Elizabeth H Arenas, PhD, University of Santo Tomas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 13, 2023

Primary Completion (Estimated)

August 30, 2024

Study Completion (Estimated)

November 30, 2024

Study Registration Dates

First Submitted

October 10, 2023

First Submitted That Met QC Criteria

October 14, 2023

First Posted (Actual)

October 23, 2023

Study Record Updates

Last Update Posted (Actual)

October 30, 2023

Last Update Submitted That Met QC Criteria

October 26, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslipidemias

Clinical Trials on Pigmented rice

Subscribe